M & A growth potentialI like the below comment from their news release in their 2nd quarter earnings.
"The Company also now has three engines of M&A growth with corporate development teams in CRH, MyHealth and WELL corporate; thereby effectively scaling the Company's inorganic growth potential."
I am most excited about CRH. The revenues reported from CRH, which did not even include a full quarter, would have justified the purchase price paid even if the earnings were the total for the entire year.
I too am puzzled but not panicked by today's price action. We need to follow the volume as much as price movement though. And with July 12 N.R. we had three million shares traded. Today, on the pull back we will have about one million shares traded. So as between the uptick on July 12 and todays' downdraft, certainly last Thursday's movement is more significant.
The positive is that we had a flushing out of shareholders who were looking to sell and a large influx of buyers who were inspired to buy based on the 2nd quarter earnings reports.
We are a very different company today than we were a year ago, and as we transition to WELL 2.0 there will be some uncertainty and this is perhaps what the market is reflecting. But those who focus exclusively on the chart arising from share price action are always going to be one step behind. You react today to the downdraft, and tomorrow you miss out on the uptick. You really cannot win with that game despite what others would lead you to believe. The best you can do is buy a good company with good management in a decent sector with reasons why it should flourish. Ultimately (and this is the key) ULTIMATELY, not immediately and when you want it to happen, the progression of the company will be reflected in its share price.